Table III.
Variables* | No MT† (N = 42) | MT† (N = 38) | Survivors (N = 61) | Nonsurvivors (N = 19) | Normal range |
---|---|---|---|---|---|
Age, y | 36 ± 13 | 32 ± 14 | 33 ± 13 | 37 ± 16 | NA |
ISS | 25 ± 9 | 34 ± 15 | 27 ± 11 | 37 ± 15 | NA |
SBP, mm Hg | 101 ± 46 | 48 ± 49 | 89 ± 51 | 38 ± 46 | 90–120 |
BD, mmol/L | 11 ± 6 | 18 ± 6 | 13 ± 7 | 19 ± 5 | 0–6 |
Lactate, mmol/L | 5.2 ± 3.3 | 11.8 ± 5.6 | 6.6 ± 4.1 | 14.0 ± 5.9 | 0–3 |
INR, s | 1.5 ± 0.4 | 2.86 ± 1.35 | 1.84 ± 0.79 | 3.14 ± 1.60 | 0.82–1.49 |
PTT, s | 35 ± 15 | 101 ± 78 | 49 ± 32 | 122 ± 98 | 20–40 |
G, dynes/cm2 | 6.5 ± 2.3 | 3.1 ± 1.7 | 5.6 ± 2.5 | 2.5 ± 1.3 | 5.1–11.0 |
Data are presented as mean ± standard error of the mean (SEM).
Massive transfusion (MR) >10 red blood cell units/2 hours).
MT, Massive transfusion; NA, not applicable; ISS, injury severity score; BD, base deficit; INR, international normalized ratio; PTT, activated partial throm-boplastin time; G, clot strength.